Hypochloremic Hypokalemic Metabolic Alkalosis as a Manifestation of CFTR‐Related Disorder
Pediatric Pulmonology · 2026-03 · 61 (3)
DOI: 10.1002/ppul.71555 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, online erschienen am 12.03.2026. Verfasst von Burcu Capraz Yavuz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ihsan Dogramaci Children's Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Alkalosis, Chlorides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Hypochloremic hypokalemic metabolic alkalosis (HHMA) may occur in unscreened, undiagnosed, and unsupplemented children with cystic fibrosis (cwCF) or in diagnosed people with CF (pwCF) who are inadequately supplemented with salt. It may also present as a clinical manifestation in children with cystic fibrosis transmembrane conductance regulator‐related disorder (cwCFTR‐RD) who have borderline or normal sweat chloride test (SCT) levels.
Methods
In this single‐center retrospective study, we included cwCF and cwCFTR‐RD who experienced at least one HHMA episode between January 2002 and August 2024. We compared the demographic, genetic, clinical, and laboratory characteristics of both groups within the context of the CFTR variant diversity observed in Türkiye.
Results
A total of 103 children (91 cwCF, 12 cwCFTR‐RD) were evaluated, comprising 150 HHMA episodes. Median SCT levels were significantly lower in cwCFTR‐RD than in cwCF (43 [IQR, 34–53] vs. 90 [IQR, 75–99] mmol/L, p < 0.001). Variants such as F1052V, D1152H, and F200I were observed in 6 of 24 variants (25%) in cwCFTR‐RD. CF‐related complications including diabetes (15.3%), chronic Pseudomonas aeruginosa infection (18%), and pancreatic insufficiency (83%) occurred only in cwCF.
Conclusion
HHMA represents an early and clinically significant manifestation in both cwCF and cwCFTR‐RD. Clearer acknowledgment of HHMA as a manifestation of CFTR‐RD within guidelines is crucial for improving diagnostic clarity and guiding appropriate management decisions. Salt supplementation, family education, and long‐term follow‐up are essential components of care for both groups. Furthermore, limited access to CFTR functional assays and the ineligibility of one‐third of cwCF for current modulators together show the ongoing diagnostic and therapeutic gaps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ihsan Dogramaci Children's Hospital, Ankara, Türkiye.
Zitieren
APA
Capraz Yavuz, B., Dogru, D., Sunman, B., Alboga, D., Kayaoglu, M. Y., Emiralioglu, N., Yalcin, E., & Ozcelik, U. (2026). Hypochloremic Hypokalemic Metabolic Alkalosis as a Manifestation of CFTR‐Related Disorder. Pediatric Pulmonology, 61(3). https://doi.org/10.1002/ppul.71555
Vancouver
Capraz Yavuz B, Dogru D, Sunman B, Alboga D, Kayaoglu MY, Emiralioglu N, et al. Hypochloremic Hypokalemic Metabolic Alkalosis as a Manifestation of CFTR‐Related Disorder. Pediatric Pulmonology. 2026;61(3). doi:10.1002/ppul.71555
BibTeX
@article{CaprazYavuz2026,
author = {Capraz Yavuz, Burcu and Dogru, Deniz and Sunman, Birce and Alboga, Didem and Kayaoglu, Meltem Yildiz and Emiralioglu, Nagehan and Yalcin, Ebru and Ozcelik, Ugur},
title = {Hypochloremic Hypokalemic Metabolic Alkalosis as a Manifestation of CFTR‐Related Disorder},
journal = {Pediatric Pulmonology},
year = {2026},
volume = {61},
number = {3},
doi = {10.1002/ppul.71555}
}
EUVIMED